申请人:Smith P. Garrick
公开号:US20060235003A1
公开(公告)日:2006-10-19
The present invention relates to compounds of formula I wherein the substituents are as defined below. The compounds of formula are useful for the treatment of diseases such as schizophrenia, including both the positive and the negative symptoms of schizophrenia and other psychoses.
本发明涉及式I的化合物,其中取代基如下所定义。式I的化合物可用于治疗疾病,如精神分裂症,包括精神分裂症的阳性症状和阴性症状以及其他精神病。